Welcome to the Grant for Multiple Sclerosis Innovation (GMSI)
The GMSI is an initiative funded by Merck KGaA, Darmstadt, Germany, to support the advancement of science and medical research in the field of multiple sclerosis (MS).
The three award winners of the 8th GMSI were announced during a virtual award ceremony that took place on Tuesday 8th September 2020. For details please go to GMSI 2020.
Applications for the 2021 award are now open.
Please contact gmsi@emdserono.com for more information.
Applications for GMSI 2021 are accepted until March 31st 2021.
Last Updated Feb 12th, 2021
US-NONNI-00446
Emails are received by administrative staff for the purpose of managing the Grant for Multiple Sclerosis Innovation (GMSI).
Please do not use the website or contact email address for any other purpose.
EMD Serono, a business of Merck KGaA, Darmstadt, Germany. This website is only intended for the USA and Canada.
Copyright ©2020 EMD Serono, Inc. All rights reserved.
